PETER LLEWELLYN-DAVIES

Peter Llewellyn-Davies is an experienced biotech executive with over 40 years of international expertise in company formation, IPOs, M&A, and financing. As Founder & CEO of Accellerate Partners, he supports management teams in scaling and implementing growth strategies. He serves as Non-Executive Director of Shield Therapeutics plc and co-founded invIOs, a company developing innovative cancer immunotherapies, including treatments for brain tumors (glioblastoma). Previously, he led the restructuring and successful sale of Apeiron Biologics to a U.S. pharmaceutical group. Peter has been recognized as a Fellow of the London Institute for Banking and Finance for his contributions to global finance.